Wynnchurch Capital Acquires Reagent Chemical & Research

Aceto Acquires IsleChem to Add U.S. Manufacturing and R&D Capabilities

December 21, 2020

Manufacturing

Aceto U.S., LLC has acquired IsleChem, a Grand Island, New York-based chemical manufacturer and contract R&D provider. The acquisition adds U.S. manufacturing, analytical and R&D capabilities to Aceto’s global specialty-chemicals sourcing and distribution platform and supports expansion of IsleChem’s facility and workforce.

Ampersand Capital Partners Acquires Nektar Therapeutics' PEG Reagent Manufacturing Business, Launches Gannet BioChem

December 2, 2024

Biotechnology

Ampersand Capital Partners has completed the acquisition of Nektar Therapeutics' PEGylation reagent manufacturing business and launched the new Ampersand portfolio company, Gannet BioChem, operating from a 124,000 sq. ft. FDA‑inspected facility in Huntsville, Alabama. The transaction represents a divestiture by Nektar and creates an independent specialty CDMO focused on development, scaling, and GMP production of polyethylene glycol (PEG) reagents for clinical and commercial biopharmaceutical customers.

CapVest Acquires Recochem from H.I.G. Capital

November 6, 2023

Manufacturing

Funds managed by CapVest Partners LLP have acquired Recochem, a global manufacturer, marketer and distributor of aftermarket transportation and household fluids, from H.I.G. Capital, which will remain a minority investor. Recochem, headquartered in Montreal, Quebec, generates revenues in excess of $1 billion and CapVest plans to support further organic growth and M&A-driven expansion.

Edgewater Capital Partners Acquires GL CHEMTEC

August 11, 2022

Pharmaceuticals

Edgewater Capital Partners, a Cleveland-based lower middle-market private equity firm, has acquired GL CHEMTEC, a chemistry-based contract research organization (CRO) headquartered in Oakville, Ontario. Edgewater will support GLC's expansion of API development, scale-up and advanced materials capabilities to accelerate growth across North American pharma and life-sciences customers.

Wynnchurch Capital Acquires Charter Industries

October 2, 2025

Building Products

Wynnchurch Capital has acquired Charter Industries, a North American vertically integrated supplier of PVC and wood edgebanding and complementary products headquartered in Grand Rapids, Michigan. The seller was Incline Equity Partners; Wynnchurch said it will support Charter's next phase of growth, expanding capabilities and pursuing strategic acquisitions.

Inhance Technologies Acquires Advance Research Chemicals

October 14, 2021

Manufacturing

Inhance Technologies, a portfolio company of Aurora Capital Partners, has completed the acquisition of Advance Research Chemicals (ARC), a specialty chemicals and materials producer with production facilities in the United States and Mexico. The add-on expands Inhance's capabilities in high-purity specialty chemicals, custom synthesis and private-label manufacturing to serve end markets including medical batteries, semiconductors, 3D printing and pharmaceuticals.